Buprenorphine treatment of opiate and
cocaine abuse: clinical and preclinical studies
by
Mello NK, Mendelson JH, Lukas SE,
Gastfriend DR, Teoh SK, Holman BL
Alcohol and Drug Abuse Research Center,
McLean Hospital-Harvard Medical School,
Belmont, MA 02178, USA.
Harv Rev Psychiatry 1993 Sep-Oct; 1(3):168-83

ABSTRACT

Buprenorphine, an opioid mixed agonist-antagonist, is a potent analgesic that appears to be effective for the treatment of opiate abuse. Recent preclinical studies have shown that buprenorphine also significantly reduces cocaine self-administration by rhesus monkeys for periods up to 120 days. This unexpected finding has led to clinical trials to evaluate buprenorphine's effectiveness for the treatment of dependence on both cocaine and opiates, as defined by DSM-III-R criteria. Buprenorphine's safety in combination with cocaine and opiates and its effects on electroencephalographic sleep patterns and regional cerebral blood flow were evaluated during inpatient studies. Buprenorphine (4 or 8 mg/day given sublingually) did not accentuate the cardiovascular and respiratory changes induced by an acute challenge dose of cocaine (30 mg given intravenously) or morphine (10 mg given intravenously) alone. In an outpatient open trial, buprenorphine significantly reduced both opiate and cocaine abuse by patients who had abused these drugs for more than 10 years. Most of these patients had failed in other drug abuse treatment programs. Reports of needle sharing also decreased significantly, and no patient tested positive for human immunodeficiency virus (HIV). The apparent safety and effectiveness of buprenorphine, combined with a high level of patient acceptance, led the Food and Drug Administration to grant a compassionate extension of the approved period for outpatient buprenorphine treatment from 26 to 52 weeks. Clinical trials of buprenorphine are ongoing. Possible mechanisms underlying buprenorphine-cocaine interactions are now under investigation.

Cocaine
Reward
Ibogaine
Agmatine
Tramadol
Methadone
Buprenorphine
Drug Screening
Chasing the dragon
Methadone v LAAM
Is morphine an antidepressant?
Tramadol versus buprenorphine
CCK and Enkephalinase Inhibitors
Buprenorphine v placebo v methadone

Refs
HOME
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family